Truvian Health announced it has raised $74m in funding for its automated benchtop blood testing analyzer, which aims to provide lab-accurate results for a comprehensive suite of routine blood tests in a single run.
The funding round was led by Wittington Ventures and Great Point Ventures with support from existing investors including DNS Capital,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?